A icon

Agilent Technologies

119.31 USD
-0.53
0.44%
Updated Jul 30, 9:58 AM EDT
1 day
-0.44%
5 days
-0.10%
1 month
1.10%
3 months
10.88%
6 months
-21.19%
Year to date
-10.58%
1 year
-14.47%
5 years
24.37%
10 years
191.21%
 

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Employees: 17,900

0
Funds holding %
of 7,323 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

18% more call options, than puts

Call options by funds: $138M | Put options by funds: $116M

13% more funds holding in top 10

Funds holding in top 10: 8 [Q4 2024] → 9 (+1) [Q1 2025]

1.16% less ownership

Funds ownership: 88.29% [Q4 2024] → 87.13% (-1.16%) [Q1 2025]

6% less funds holding

Funds holding: 1,061 [Q4 2024] → 1,001 (-60) [Q1 2025]

14% less capital invested

Capital invested by funds: $33.9B [Q4 2024] → $29B (-$4.85B) [Q1 2025]

17% less repeat investments, than reductions

Existing positions increased: 330 | Existing positions reduced: 398

31% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 140

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$125
5%
upside
Avg. target
$136
14%
upside
High target
$155
30%
upside

5 analyst ratings

positive
40%
neutral
60%
negative
0%
Evercore ISI Group
Vijay Kumar
9%upside
$130
In-Line
Maintained
8 Jul 2025
Barclays
Luke Sergott
5%upside
$125
Equal-Weight
Maintained
24 Jun 2025
UBS
Elizabeth Garcia
9%upside
$130
Neutral
Maintained
29 May 2025
JP Morgan
Tycho Peterson
30%upside
$155
Overweight
Maintained
29 May 2025
Baird
Catherine Schulte
17%upside
$140
Outperform
Maintained
22 May 2025

Financial journalist opinion

Based on 3 articles about A published over the past 30 days

Positive
Reuters
1 day ago
Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says
U.S.-based laboratory equipment maker Agilent Technologies plans to double its investments in India to expand in one of its fastest-growing markets, a top executive said.
Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says
Neutral
Business Wire
1 week ago
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
SANTA CLARA, Calif.--(BUSINESS WIRE)--Following an announcement earlier this week, Agilent Technologies Inc. (NYSE: A) confirms it will release financial results for the third quarter of fiscal year 2025 after the stock market closes on Wednesday, Aug. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT on the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A rec.
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27
Neutral
Business Wire
2 weeks ago
Agilent Announces CFO Transition
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his role as he relocates to the East Coast for family reasons and prepares for the next chapter in his career. Following McMahon's departure, Rodney Gonsalves, Agilent's current corporate controller and principal accounting officer, will additionally serve as interim CFO until McMahon's successor is na.
Agilent Announces CFO Transition
Neutral
Benzinga
1 month ago
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Positive
Zacks Investment Research
1 month ago
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Neutral
Business Wire
1 month ago
Agilent to Showcase New Products and Innovations at HPLC 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes. The Agilent Infinit.
Agilent to Showcase New Products and Innovations at HPLC 2025
Neutral
Seeking Alpha
1 month ago
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Neutral
Zacks Investment Research
1 month ago
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Neutral
Zacks Investment Research
2 months ago
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Neutral
Seeking Alpha
2 months ago
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SVP and CFO Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Michael Ryskin - Bank of America Dan Leonard - UBS Operator Good afternoon.
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Charts implemented using Lightweight Charts™